May & Baker Nigeria plc (NGSE: MAYBAKER)
Health Care · Pharmaceuticals · NG
₦37.00
-7.50% today · +105.0% 1Y
May & Baker Nigeria plc (NGSE: MAYBAKER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $47.39M.
Over the last twelve months the share price has gained 105.0%, trading between 15.70 and 52.50.
Tweenvest scores May & Baker Nigeria plc across four factors: quality 72/100, value 37/100, growth 88/100, dividend 90/100. Its strongest factor is dividend.
MAYBAKER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $47.39M
- Revenue (TTM)
- $27.71M
- P/E
- 11.71
- EPS
- 3.16
- Dividend yield
- 1.08%
- Beta (5Y)
- 0.69
- 52-week high
- ₦52.50
- 52-week low
- ₦15.70
- Avg volume (3M)
- —
- Shares outstanding
- 1.73B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.15 | -0.30% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.25 | +0.08% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.17 | +3.66% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.51 | +1.93% |
Figures last refreshed Aug 18, 2026.